Patents by Inventor Dana Yen Mei Duey

Dana Yen Mei Duey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ILT-BINDING AGENTS AND METHODS OF USE THEREOF
    Publication number: 20240025997
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind ILT2, ILT4, or both ILT2 and ILT4, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
    Type: Application
    Filed: September 13, 2023
    Publication date: January 25, 2024
    Applicant: NGM Biopharmaceuticals, Inc.
    Inventors: Dana Yen Mei Duey, Allen James Ebens, Jr., Daniel David Kaplan, Chia-Ying Kao Lam, Kalyani Mondal, Geoffrey William Stone, Yan Wang
  • IL-8 ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20230416355
    Abstract: Described herein are anti-IL-8 antibodies, compositions thereof, and methods of use thereof. The anti-IL-8 antibodies N would be useful in methods of inhibiting tumor formation or growth or a combination thereof. Described herein are also methods of using the anti-IL-8 antibodies for methods of treating a disease, wherein diseases may include cancer, a tumor, or a viral infection.
    Type: Application
    Filed: August 5, 2021
    Publication date: December 28, 2023
    Applicant: STELEXIS THERAPEUTICS, LLC
    Inventors: Keren Paz, Nicole Covino, Yasumi Nakayama, Patrick James Doyle, Carmine Carpenito, Lynn Biderman, Bozena Bugaj-Gaweda, John Andrew Lippincott, Dana Yen Mei Duey
  • C3-BINDING AGENTS AND METHODS OF USE THEREOF
    Publication number: 20230382985
    Abstract: The present disclosure provides binding agents, such as antibodies (including single chain variable fragments), that specifically bind complement component C3, including human C3, compositions comprising same, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising same.
    Type: Application
    Filed: August 10, 2023
    Publication date: November 30, 2023
    Inventors: Dana Yen Mei Duey, Zhonghao Liu, Jie Tang, Yan Wang, Yiyuan Yin, Wenwu Zhai, Jared Martin Higbee
  • ILT-binding agents and methods of use thereof
    Patent number: 11802155
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind ILT2, ILT4, or both ILT2 and ILT4, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
    Type: Grant
    Filed: April 29, 2021
    Date of Patent: October 31, 2023
    Assignee: NGM Biopharmaceuticals, Inc.
    Inventors: Dana Yen Mei Duey, Allen James Ebens, Jr., Daniel David Kaplan, Chia-Ying Kao Lam, Kalyani Mondal, Geoffrey William Stone, Yan Wang
  • C3-binding agents and methods of use thereof
    Patent number: 11767359
    Abstract: The present disclosure provides binding agents, such as antibodies (including single chain variable fragments), that specifically bind complement component C3, including human C3, compositions comprising same, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising same.
    Type: Grant
    Filed: August 19, 2021
    Date of Patent: September 26, 2023
    Assignee: NGM Biopharmaceuticals, Inc.
    Inventors: Dana Yen Mei Duey, Zhonghao Liu, Jie Tang, Yan Wang, Yiyuan Yin, Wenwu Zhai, Jared Martin Higbee
  • C3-BINDING AGENTS AND METHODS OF USE THEREOF
    Publication number: 20220119508
    Abstract: The present disclosure provides binding agents, such as antibodies (including single chain variable fragments), that specifically bind complement component C3, including human C3, compositions comprising same, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising same.
    Type: Application
    Filed: August 19, 2021
    Publication date: April 21, 2022
    Inventors: Dana Yen Mei Duey, Zhonghao Liu, Jie Tang, Yan Wang, Yiyuan Yin, Wenwu Zhai, Jared Martin Higbee
  • ILT-BINDING AGENTS AND METHODS OF USE THEREOF
    Publication number: 20210355211
    Abstract: The present disclosure provides binding agents, such as antibodies, that specifically bind ILT2, ILT4, or both ILT2 and ILT4, as well as compositions comprising the binding agents, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising the binding agents.
    Type: Application
    Filed: April 29, 2021
    Publication date: November 18, 2021
    Inventors: Dana Yen Mei Duey, Allen James Ebens, JR., Daniel David Kaplan, Chia-Ying Kao Lam, Kalyani Mondal, Geoffrey William Stone, Yan Wang
  • Anti-C3 antibodies
    Patent number: 11136381
    Abstract: The present disclosure provides binding agents, such as antibodies (including single chain variable fragments), that specifically bind complement component C3, including human C3, compositions comprising same, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising same.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: October 5, 2021
    Assignee: NGM Biopharmaceuticals, Inc.
    Inventors: Dana Yen Mei Duey, Zhonghao Liu, Jie Tang, Yan Wang, Yiyuan Yin, Wenwu Zhai, Jared Martin Higbee
  • C3-BINDING AGENTS AND METHODS OF USE THEREOF
    Publication number: 20190322730
    Abstract: The present disclosure provides binding agents, such as antibodies (including single chain variable fragments), that specifically bind complement component C3, including human C3, compositions comprising same, and methods of their use. The disclosure also provides related polynucleotides and vectors encoding the binding agents and cells comprising same.
    Type: Application
    Filed: April 1, 2019
    Publication date: October 24, 2019
    Inventors: Dana Yen Mei Duey, Zhonghao Liu, Jie Tang, Yan Wang, Yiyuan Yin, Wenwu Zhai, Jared Martin Higbee